republic-os/legislation/us/states/fl/2024/hb-885.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, chapter_law, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	chapter_law	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Coverage for Biomarker Testing	Coverage for Biomarker Testing; Requires DMS to provide coverage of biomarker testing for specified purposes for state employees' state group health insurance plan policies; authorizes AHCA to pay for biomarker testing under Medicaid program for specified purposes, subject to specific appropriations; requires managed care plans under contract with agency in Medicaid program to provide coverage for biomarker testing for Medicaid recipients in certain manner; specifies circumstances under which such coverage may be provided; requires clear, convenient, & readily accessible process for authorization requests for biomarker testing.	us/states/fl	Florida Legislature	2024	HB 885	Florida HB 885 (2024)	bill	insurance public officers employees and records social welfare	enacted	2024-249	Gonzalez Pittman	5	46	2	2023-12-13	2024-06-19	openstates	ocd-bill/c34548be-1b7f-4fc0-ad7e-80a6ab1fada0	https://flsenate.gov/Session/Bill/2024/885/ByCategory	2d30a4fc5aa9e181259ef83df946f973cf17f36c6831846f782f7fb92f1a9b3f	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-fl

Florida HB 885 (2024) — Coverage for Biomarker Testing

Coverage for Biomarker Testing; Requires DMS to provide coverage of biomarker testing for specified purposes for state employees' state group health insurance plan policies; authorizes AHCA to pay for biomarker testing under Medicaid program for specified purposes, subject to specific appropriations; requires managed care plans under contract with agency in Medicaid program to provide coverage for biomarker testing for Medicaid recipients in certain manner; specifies circumstances under which such coverage may be provided; requires clear, convenient, & readily accessible process for authorization requests for biomarker testing.

Enacted — Laws of Florida, Chapter 2024-249.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. H 885 Filed (filed) — source
2. H 885 c1 (committee substitute) — source
3. H 885 c2 (committee substitute) — source
4. H 885 e1 (engrossed) — source
5. H 885 er (enrolled) — source

Votes

• Passage, Third Reading — 114–0 (pass) · lower
• Third Reading — 39–0 (pass) · upper

Sponsors

• Gonzalez Pittman — primary (person)
• Health & Human Services Committee — primary (organization)
• Select Committee on Health Innovation — primary (organization)
• Anderson — cosponsor (person)
• Bartleman — cosponsor (person)
• Basabe — cosponsor (person)
• Benjamin — cosponsor (person)
• Berfield — cosponsor (person)
• Cross — cosponsor (person)
• Gossett-Seidman — cosponsor (person)
• Lopez, V. — cosponsor (person)
• López, J. — cosponsor (person)
• Mooney — cosponsor (person)
• Salzman — cosponsor (person)
• Trabulsy — cosponsor (person)
• Williams — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2023-12-13 Filed filing
• 2023-12-27 Referred to Select Committee on Health Innovation referral-committee
• 2023-12-27 Referred to Appropriations Committee referral-committee
• 2023-12-27 Referred to Health & Human Services Committee referral-committee
• 2023-12-27 Now in Select Committee on Health Innovation
• 2024-01-09 1st Reading (Original Filed Version) filing, reading-1
• 2024-01-18 Added to Select Committee on Health Innovation agenda
• 2024-01-22 Favorable with CS by Select Committee on Health Innovation committee-passage-favorable
• 2024-01-23 Reported out of Select Committee on Health Innovation
• 2024-01-24 Laid on Table under Rule 7.18(a) deferral
• 2024-01-24 CS Filed filing
• 2024-01-25 1st Reading (Committee Substitute 1) reading-1
• 2024-01-25 Referred to Appropriations Committee referral-committee
• 2024-01-25 Referred to Health & Human Services Committee referral-committee
• 2024-01-25 Now in Appropriations Committee
• 2024-02-06 Added to Appropriations Committee agenda
• 2024-02-08 Favorable by Appropriations Committee committee-passage-favorable
• 2024-02-08 Reported out of Appropriations Committee
• 2024-02-08 Now in Health & Human Services Committee
• 2024-02-20 Added to Health & Human Services Committee agenda
• 2024-02-22 Favorable with CS by Health & Human Services Committee committee-passage-favorable
• 2024-02-23 Reported out of Health & Human Services Committee
• 2024-02-23 Laid on Table under Rule 7.18(a) deferral
• 2024-02-23 CS Filed filing
• 2024-02-26 Bill referred to House Calendar
• 2024-02-26 Bill added to Special Order Calendar (2/29/2024)
• 2024-02-26 1st Reading (Committee Substitute 2) reading-1
• 2024-02-29 Read 2nd time reading-2
• 2024-02-29 Amendment 718117 adopted
• 2024-02-29 Added to Third Reading Calendar
• 2024-02-29 Read 3rd time reading-3
• 2024-02-29 CS passed as amended; YEAS 114, NAYS 0 passage
• 2024-02-29 In Messages
• 2024-02-29 Referred to Fiscal Policy referral-committee
• 2024-02-29 Received enrolled
• 2024-03-05 Withdrawn from Fiscal Policy withdrawal
• 2024-03-05 Placed on Calendar, on 2nd reading
• 2024-03-05 Substituted for CS/CS/SB 964
• 2024-03-05 Read 2nd time reading-2
• 2024-03-05 Read 3rd time reading-3
• 2024-03-05 CS passed; YEAS 39 NAYS 0 passage
• 2024-03-05 In Messages
• 2024-03-05 Ordered enrolled enrolled
• 2024-06-17 Signed by Officers and presented to Governor executive-receipt
• 2024-06-18 Approved by Governor executive-signature
• 2024-06-19 Chapter No. 2024-249

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/c34548be-1b7f-4fc0-ad7e-80a6ab1fada0. Confidence: reported (aggregated from official Florida legislature records).